MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, RLAY made $15,355K in revenue. -$274,755K in net income. Net profit margin of -1789.35%.

Income Overview

Revenue
$15,355K
Net Income
-$274,755K
Net Profit Margin
-1789.35%
EPS
-$1.61
Unit: Thousand (K) dollars
Revenue Breakdown
    • License and other revenue

Income Statement
2025-12-31
Total revenue
15,355
Research and development expenses
261,383
General and administrative expenses
56,710
Total operating expenses
318,093
Loss from operations
-302,738
Interest income
27,035
Other (expense) income
-776
Total other income, net
26,259
Net loss
-276,479
Unrealized holding gain (loss)
1,724
Total other comprehensive income (loss)
1,724
Total comprehensive loss
-274,755
Basic EPS
-1.61
Diluted EPS
-1.61
Basic Average Shares
171,586,558
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Unrealized holding gain(loss)$1,724K Total comprehensiveloss-$274,755K Total othercomprehensive income (loss)$1,724K Interest income$27,035K Net loss-$276,479K Total other income,net$26,259K License and otherrevenue$15,355K Other (expense)income-$776K Loss from operations-$302,738K Total revenue$15,355K Total operatingexpenses$318,093K Research and developmentexpenses$261,383K General andadministrative expenses$56,710K

Relay Therapeutics, Inc. (RLAY)

Relay Therapeutics, Inc. (RLAY)